Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Romark Global Pharma
AddedMar 19, 2024
UpdatedJun 18, 2026
Romark Global Pharma

Romark Global Pharma

Public

Innovative pharmaceuticals for global health.

HQ
Tampa, FL, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Romark Global Pharma, founded with a mission to discover, develop, and commercialize innovative small molecules, focuses on treating infectious diseases and cancers. The company is dedicated to scientific discovery and aims to make significant contributions to global health. Romark offers a range of pharmaceutical drugs designed to address viral respiratory infections and chronic conditions like hepatitis B.

Notable figures affiliated with Romark include its team of passionate scientists and researchers committed to advancing medical treatments. The company has achieved significant milestones, with millions of people worldwide benefiting from its products. Romark's impact is evident in its contributions to the pharmaceutical industry, particularly in developing new treatments for viral infections and chronic diseases.

Romark Global Pharma - Similar Companies

Quark Pharmaceuticals logo

Quark Pharmaceuticals

Biomarck Pharmaceuticals logo

Biomarck Pharmaceuticals

Gemmus Pharma logo

Gemmus Pharma

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Enanta Pharmaceuticals logo

Enanta Pharmaceuticals

enanta.com

Globavir Biosciences logo

Globavir Biosciences

Merck & CO INC Cedear EAC 5 RE logo

Merck & CO INC Cedear EAC 5 RE

merck.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Pharmos logo

Pharmos

pharmoscorp.com

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Gilead Sciences logo

Gilead Sciences

gilead.com

Rigel Pharmaceuticals logo

Rigel Pharmaceuticals

rigel.com

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

MBC Pharma logo

MBC Pharma

mbcpharma.com

Romark Global Pharma - Quick Facts

Who are Romark Global Pharma's competitors?

Companies similar to Romark Global Pharma include Quark Pharmaceuticals, Biomarck Pharmaceuticals, Gemmus Pharma and Bayer Pharmaceuticals.

When was Romark Global Pharma founded?

Romark Global Pharma was founded in 2014.

Where is Romark Global Pharma's headquarters located?

Romark Global Pharma's headquarters is located in Tampa, FL, US.

When was Romark Global Pharma's last funding round?

Romark Global Pharma's most recent funding round was for $10.7M (USD) in March 2016.

How much has Romark Global Pharma raised to-date?

As of Mar 15, 2016, Romark Global Pharma has raised a total of $78.4M (USD).

How many employees does Romark Global Pharma have?

Romark Global Pharma has 75 employees as of Feb 5, 2024.

Romark Global Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Drugs
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research